Literature DB >> 27608474

Probiotics and refractory chronic spontaneous urticaria.

E Nettis1, E Di Leo2, A Pastore3, M Distaso3, I Zaza3, M Vacca3, L Macchia3, A Vacca3.   

Abstract

Background. In chronic spontaneous urticaria (CSU) first-line therapy with an antihistamine-based regimen may not achieve satisfactory control in patients. Thus, a continuing need exists for effective and safe treatments for refractory CSU. Aim. To evaluate the clinical efficacy and safety of an intake of a combination of 2 probiotics (Lactobacillus salivarius LS01 and Bifidobacterium breve BR03) in patients with CSU who remain symptomatic despite concomitant H1-antihistamine therapy. Methods. This report analyzes the effects of therapy with two probiotic strains on the clinical progress of 52 unselected patients with difficulty to treat CSU underwent to medical examination in two Italian specialist urticaria Clinics between September 2013 and September 2014. A mixture of Lactobacillus LS01 and Bifidobacterium BR03 were administered in each patient twice daily for 8 weeks. To evaluate patients' improvement with probiotics, urticaria activity score over 7 days (UAS7) was used at baseline and at week 8 in addition to a 5-question urticaria quality of life questionnaire. Results. Fifty-two patients with CSU were included in this study (10 male and 42 female, age range 19-72 years). Mean disease duration was 1.5 years. Fourteen patients discontinued treatment, so evaluable population consisted of 38 patients. Nine of the 38 patients experienced mild clinical improvement during probiotic treatment (23.7%); one patient reported significant clinical improvement (2.6%) and one patient had complete remission of urticaria (2.6%). Twenty-seven patients did not have improvement in symptoms (71.1%). No side effects during the course of therapy were reported. Conclusions. A combination of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03 administered twice daily for 8 weeks might reduce the symptoms scores and improve quality of life scores in a part of patients with CSU who remained symptomatic despite treatment with H1 antihistamine mostly in subjects with allergic rhinitis.

Entities:  

Keywords:  Bifidobacterium breve; Chronic spontaneous urticaria; H1-antihistamine therapy; Lactobacillus salivarius

Mesh:

Substances:

Year:  2016        PMID: 27608474

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  7 in total

Review 1.  Ligilactobacillus salivarius functionalities, applications, and manufacturing challenges.

Authors:  M Guerrero Sanchez; S Passot; S Campoy; M Olivares; F Fonseca
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

2.  A post hoc analysis on the effects of a probiotic mixture on asthma exacerbation frequency in schoolchildren.

Authors:  Lorenzo Drago; Luigi Cioffi; Maria Giuliano; Marco Pane; Giorgio Ciprandi
Journal:  ERJ Open Res       Date:  2022-05-09

3.  Mild cutaneous reactions to drugs.

Authors:  Giuseppe Crisafulli; Fabrizio Franceschini; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Francesca Saretta; Roberto Bernardini; Fabio Cardinale; Francesca Mori; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-28

4.  Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial.

Authors:  Xiao-Dong Bi; Bao-Zhen Lu; Xin-Xin Pan; Sha Liu; Jiu-Yao Wang
Journal:  Allergy Asthma Clin Immunol       Date:  2021-04-17       Impact factor: 3.406

5.  The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706).

Authors:  Lorenzo Drago; Luigi Cioffi; Maria Giuliano; Marco Pane; Angela Amoruso; Irene Schiavetti; Gregor Reid; Giorgio Ciprandi
Journal:  J Immunol Res       Date:  2022-01-17       Impact factor: 4.818

6.  Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation.

Authors:  Yao Song; Kena Dan; Zhengqiu Yao; Xi Yang; Bangtao Chen; Fei Hao
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

Review 7.  Probiotics in Children with Asthma.

Authors:  Giorgio Ciprandi; Maria Angela Tosca
Journal:  Children (Basel)       Date:  2022-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.